Effect of glycemic control on glucose counterregulation during hypoglycemia in NIDDM

Diabetes Care

Volumn 21, Issue 8, 1998, Pages 1330-1338

  Levy, Carol J ^a,c   Kinsley, Brendan T ^a,b   Bajaj, Mandeep ^a   Simonson, Donald C ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CORTICOTROPIN; GLYCOSYLATED HEMOGLOBIN; GROWTH HORMONE; HYDROCORTISONE; NORADRENALIN;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL ARTICLE; FEMALE; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; HORMONE RELEASE; HORMONE RESPONSE; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT SELECTION; REGULATORY MECHANISM; RISK ASSESSMENT;

ADRENOCORTICOTROPIC HORMONE; ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; EPINEPHRINE; FEMALE; GLUCAGON; HEMOGLOBIN A, GLYCOSYLATED; HOMEOSTASIS; HORMONES; HUMAN GROWTH HORMONE; HUMANS; HYDROCORTISONE; HYPOGLYCEMIA; MALE; MIDDLE AGED; NOREPINEPHRINE; REFERENCE VALUES; REGRESSION ANALYSIS; TIME FACTORS;

EID: 0031929129     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.21.8.1330     Document Type: Article

References (66)

1. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications of insulin dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
2. The Diabetes Control and Complications Trial Research Group: Epidemiology of severe hypoglycemia in the diabetes control and complications trial. Am J Med 90:450-459, 1991
3. Reichard P, Pihl M: Mortality and treatment side-effects during long-term intensified conventional insulin treatment in the Stockholm Diabetes Intervention Study. Diabetes 43:313-317, 1994
4. Wang PH, Lau J, Chalmers TC: Metaanalysis of the effects of intensive glycemic control on late complications of type 1 diabetes mellitus. Online J Curr Clin Trials 21 May 1993 (Doc. No. 60)
5. Colwell JA: DCCT findings: applicability and implications for NIDDM. Diabetes Rev 2:277-291, 1994
6. Clark CM, Vinicor F: Introduction: risks and benefits of intensive management in NIDDM. The fifth Regenstrief Conference. Ann Intern Med 124:81-85, 1996
7. Boden G, Soriano M, Hoeldtke RD, Owen OE: Counterregulatory hormone release and glucose recovery after hypoglycemia in non-insulin dependent diabetic patients. Diabetes 32:1055-1059, 1983
8. Polonsky KS, Herold KC, Gilden JL, Bergenstal RM, Fang VS, Moosa AR, Jaspan JB: Glucose counterregulation in patients after pancreatectomy: comparison with other clinical forms of diabetes. Diabetes 33:1112-1119, 1984
9. Heller SR, Macdonald IA, Tattersall RB: Counterregulation in type 2 diabetes mellitus: normal endocrine and glycaemic responses up to ten years after diagnosis. Diabetologia 30:924-929, 1987
10. Bolli GB, Tsalikian E, Haymond MN, Cryer PE, Gerich JE: Defective glucose counter-regulation after subcutaneous insulin in non-insulin dependent diabetes mellitus. J Clin Invest 73:1532-1541, 1984
11. Menielly GS, Cheung E, Tyokko H: Counterregulatory responses to hypoglycemia in the elderly patient with diabetes. Diabetes 43:403-410, 1994
12. Shamoon H, Friedman S, Canton C, Zacharowicz L, Hu M, Rossetti L: Increased epinephrine and skeletal muscle responses to hypoglycemia in non-insulin dependent diabetic patients. J Clin Invest 93:2562-2571, 1994
13. Colwell JA: Intensive insulin therapy in type II diabetes: rationale and collaborative clinical trial results. Diabetes 45 (Suppl. 3): S87-S90, 1996
14. Korzon-Burakowska A, Hopkins D, Matyka K, Lomas J, Pernet A, Macdonald I, Amiel S: Effects of glycemic control on protective responses against hypoglycemia in type 2 diabetes. Diabetes Care 21:283-290, 1998
15. Henry RR, Gumbiner B, Ditzler T, Wallace P, Lyon R, Glauber HS: Intensive conventional insulin therapy for type II diabetes: metabolic effects during a 6-month outpatient trial. Diabetes Care 16:21-31, 1993
16. Abraira C, Colwell JA, Nuttall FQ, Swain CT, Johnson Nagel N, Comstock JP, Emanuele NV, Levin SR, Henderson W, Lee HS: Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM): results of the feasibility trial. Diabetes Care 18:1113-1123, 1995
17. Kinsley BT, Widom B, Simonson DC: Differential regulation of counterregulatory hormone secretion and symptoms during hypoglycemia in IDDM. Diabetes Care 18:17-26, 1995
18. Ewing DJ, Clarke BF: Diagnosis and management of diabetic autonomic neuropathy. Br Med J 285:916-918, 1982
19. McGuire EA, Helderman JH, Tobin JD, Andres R, Berman M: Effect of arterial versus venous sampling on analysis of glucose kinetics in man. J Appl Physiol 41:565-573, 1976
20. DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223, 1979
21. Widom B, Simonson DC: Glycemic control and neuropsychologic function during hypoglycemia in patients with insulin-dependent diabetes mellitus. Ann Intern Med 112:904-912, 1990
22. Hepburn DA, Deary IJ, Frier BM, Patrick AN, Quinn JD, Fisher BM: Symptoms of acute hypoglycemia in humans with and without IDDM. Diabetes Care 14:949-955, 1991
23. Hepburn DA, Deary IJ, Frier BM: Classification of symptoms of hypoglycemia in insulin-treated diabetic patients using factor analysis: relationship to hypoglycaemia unawareness. Diabet Med 9:70-75, 1992
24. Deary IJ, Hepburn DA, Macleod KM, Frier BM: Partitioning the symptoms of hypoglycemia using multiple-sample confirmatory factor analysis. Diabetologia 36:771-777, 1993
25. Soeldner JS, Slone D: Critical variables in the radioimmunoassay of serum insulin using the double antibody technique. Diabetes 14:771-779, 1965
26. Menard L, Dempsey ME, Blankstein LA, Aleyassine H, Walls M, Soeldner JS: Quantitative determination of glycosylated hemoglobin Al by agar gel electrophoresis. Clin Chem 26:1598-1602, 1980
27. Tasserson SJ, Fiolet JW, Wilebrands JW: Evaluation of the radioenzymatic kit for determination of plasma catecholamines. Clin Chem 26:120-122, 1980
28. Boden G, Soeldner JS: A sensitive double antibody radioimmunoassay for human growth hormone. Diabetologa 3:413-421, 1967
29. Weir GC, Turner RC, Martin DB: Glucagon radioimmunoassay using antiserum 30K: interference by plasma. Horm Metab Res 5:241-244, 1973
30. Foster LB, Dunn RT: Single antibody technique for radioimmunoassay for cortisol in unextracted serum or plasma. Clin Chem 20:365-368, 1974
31. White A, Smith H, Hoadley M, Dobson SH, Ratcliffe JG: Clinical evaluation of a two-site immunoradiometric assay for adrenocorticotropin in unextracted human plasma using monoclonal antibodies. Clin Endocrinol 26:41-52, 1987
32. Amiel SA, Sherwin RS, Simonson DC, Tamborlane WV: Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release. Diabetes 37:901-907, 1988
33. Clutter WE, Bier DM, Shah SD, Cryer PE: Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic hemodynamic actions in man. J Clin Invest 66:94-101, 1980
34. Heine RJ: Methods of investigation of insulin induced hypoglycemia. In Hypoglycemia and Diabetes. Frier BM, Fisher BM, Eds. London, Edward Arnold, 1993, p. 165-175
35. Kinsley BT, Simonson DC: Evidence for a hypothalamic-pituitary versus adrenal cortical effect of glycemic control on counter-regulatory hormone response to hypoglycemia in insulin dependent diabetes mellitus. J Clin Endocrinol Metab 81:684-691, 1996
36. Rizza RA, Cryer PE, Gerich JE: Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. J Clin Invest 62:62-71, 1979
37. Gerich JE, Langlois M, Noacco C, Karam JH, Forsham PH: Lack of glucagon response to hypoglycemia in diabetes: evidence for an intrinsic pancreatic alpha cell defect. Science 182:171-173, 1973
38. Bolli G, DeFeo P, Compagnucci P, Cartechimi MG, Angeletti G, Santeusanio F, Brunetti P, Gerich JE: Abnormal glucose counterregulation in insulin dependent diabetes mellitus: interaction of anti-insulin antibodies and impaired glucagon response. Diabetes 32:134-141, 1983
39. Stagner JI, Samols E: The vascular order of islet cellular perfusion in the human pancreas. Diabetes 41:93-97, 1992
40. Simonson DC, Tamborlane WV, Defronzo RA, Sherwin RS: Intensive insulin therapy reduces counterregulatory hormone responses to hypoglycemia in patients with type 1 diabetes. Ann Int Med 103:184-190, 1985
41. Amiel SA, Tamborlane WV, Simonson D, Sherwin RS: Defective glucose counterregulation after strict control of insulin dependent diabetes mellitus. N Engl J Med 316:1376-1383, 1987
42. Heller SR, Cryer PE: Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans. Diabetes 40:223-226, 1991
43. Widom B, Simonson DC: Intermittent hypoglycemia impairs glucose counterregulation. Diabetes 41:1597-1602, 1992
44. Cryer PE: Banting Lecture: hypoglycemia: the limiting factor in the management of IDDM. Diabetes 43:1378-1389, 1994
45. Boyle PJ, Nagy RJ, O'Connor A, Kempers SF, Yeo RA, Qualls C: Adaptation in brain glucose uptake following recurrent hypoglycemia. Proc Natl Acad Sci U S A 91:9352- 9356, 1994
46. Boyle PJ, Kempers SF, O'Connor AM, Nagy RJ: Brain glucose uptake and unawareness of hypoglycemia in patients with insulin dependent diabetes mellitus. N Engl J Med 333:1726-1731, 1995
47. Boyle PJ, Schwartz NS, Shah SD, Clutter WE, Cryer PE: Plasma glucose concentrations at the onset of hypoglycemic symptoms in patients with poorly controlled diabetes and in non-diabetics. N Engl J Med 318:1487-1492, 1988
48. Ortiz-Alonso J, Galecki A, Herman WH, Smith AJ, Jacquez JA, Halter JB: Hypoglycemia counterregulation in elderly humans: relationship to glucose levels. Am J Physiol 267:E497-E506, 1994
49. Esler MD, Turner AG, Kaye DM, Thompson JM, Kingwell BA, Morris M, Lambert GW, Jennings GL, Cox HS, Seals DR: Aging effects on human sympathetic neuronal function. Am J Physiol 268:R278-R285, 1995
50. Vermes I, Steinmetz E, Schoorl J, van der Veen EA, Tilders FJH: Increased plasma levels of immunoreactive β-endorphin and corticotropin in non-insulin dependent diabetes mellitus (Letter). Lancet 2:725-726, 1985
51. Hashimoto K, Nishioka T, Takao T, Numata Y: Low plasma corticotropin-releasing hormone (CRH) levels in patients with noninsulin dependent diabetes mellitus. Endocrin J 40:705-709, 1993
52. Feinglos MN, Surwit RS, McCaskill CC, Ross SI: Plasma levels of β-endorphin and adrenocorticotropic hormone in IDDM and NIDDM (Letter). Diabetes Care 15:590-591, 1992
53. Solerte SB, Fioravanti M, Petraglia F, Facchinetti F, Patti AL, Schifino N, Genazzi AR, Ferrari E: Plasma beta-endorphin, free fatty acids, and blood lipid changes in type 2 (non-insulin dependent) diabetic patients. J Endocrinol Invest 11:37-42, 1988
54. Frier BM, Fisher BM, Gray CE, Beastall GH: Counterregulatory hormonal responses to hypoglycemia in type 1 (insulin dependent) diabetes: evidence for diminished hypothalamic-pituitary hormonal secretion. Diabetologia 31:421-429, 1988
55. Roy MS, Roy A, Gallucci WT, Collier B, Young K, Kamilaris TC, Chrousos GP: The ovine corticotropin-releasing hormone-stimulation test in type I diabetic patients and controls: suggestion of mild chronic hypercortisolism. Metabolism 42:696-700, 1993
56. Lingenfelser T, Renn W, Sommerwerck U, Jung ME Buettner UW, Zaiser-Kaschel H, Eggstein M, Jakober B: Compromised hormonal counterregulation, symptom awareness, and neurophysiological function after recurrent short-term episodes of insulin induced hypoglycemia in IDDM patients. Diabetes 42:610-618, 1993
57. Rudman D, Kutner MH, Rogers CM, Lubin MF, Fleming GA, Bain RP: Impaired growth hormone secretion in the adult population: relation to age and adiposity. J Clin Invest 67:1361-1369, 1981
58. Kopelman PG, Noonan K, Goulton R, Forrest AJ: Impaired growth hormone response to growth hormone releasing factor and insulin-hypoglycemia in obesity. Clin Endocrinol 23:87-94, 1985
59. Kelijman M: Age related alterations of the growth hormone/insulin like growth factor axis. J Am Geriatr Soc 39:295-307, 1991
60. DeFronzo RA, Simonson DC, Ferrannini E: Hepatic and peripheral insulin resistance: a common feature of type 2 (non-insulin- dependent) and type 1 (insulin-dependent) diabetes mellitus. Diabetologia 23:313-319, 1982
61. Davis SN, Goldstein RE, Jacobs J, Price L, Wolf R, Cherrington AD: The effects of differing insulin levels on the hormonal and metabolic response to hypoglycemia in normal humans. Diabetes 42:263-272, 1993
62. Davis MR, Melman M, Shamoon H: Physiologic hyperinsulinemia enhances counter- regulatory hormone responses to hypoglycemia in IDDM. J Clin Endocrinol Metab 76:1983-1385, 1993
63. Kerr D, Reza M, Smith N, Leatherdale BA: Importance of insulin in subjective, cognitive, and hormonal responses to hypoglycemia in patients with IDDM. Diabetes 40:1057-1062, 1991
64. Fanelli C, Pampanelli S, Epifano L, Rambotti AM, Ciofetta M, Modarelli F, DeVincenzo A, Annibale B, Lepore M, Lalli C, Sindaco PD, Brunetti P, Bolli GB: Relative roles of insulin and hypoglycemia on neuroendocrine responses to, symptoms of, and deterioration in cognitive function in hypoglycemia in male and female humans. Dia betologia 37:797-807, 1994
65. Diamond MP, Hallarman L, Starick-Zych K, Jones TW, Connolly-Howard M, Tamborlane WV, Sherwin RS: Suppression of coun terregulatory response to hypoglycemia by insulin per se. J Clin Endocrinol Metab 72:1388-1390, 1991
66. Hepburn DA, McLeod KM, Pell ACH, Scougal IJ, Frier BM: Frequency and symptoms of hypoglycemia experienced by patients with type 2 diabetes treated with insulin. Diabet Med 10:231-237, 1993